Travere Therapeutics (TVTX)
(Real Time Quote from BATS)
$12.89 USD
+1.91 (17.40%)
Updated Sep 9, 2024 03:10 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.71 |
EPS Last Quarter | -0.90 |
Last EPS Surprise | -3.45% |
ABR | 1.40 |
Earnings ESP
|
1.41% |
---|---|
Current Year | -3.96 |
Next Year | -1.65 |
EPS (TTM) | -4.99 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 59.01M | 62.77M | 217.28M | 332.50M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 76.20M | 69.38M | 237.20M | 512.12M |
Low Estimate | 46.80M | 49.20M | 191.49M | 262.27M |
Year ago Sales | 37.10M | 45.06M | 198.84M | 217.28M |
Year over Year Growth Est. | 59.06% | 39.30% | 9.27% | 53.03% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.71 | -0.70 | -3.96 | -1.65 |
# of Estimates | 8 | 7 | 7 | 8 |
Most Recent Consensus | -0.63 | -0.56 | -3.86 | -0.58 |
High Estimate | -0.57 | -0.55 | -3.70 | 0.27 |
Low Estimate | -0.97 | -0.96 | -4.54 | -2.42 |
Year ago EPS | -1.17 | -1.16 | -5.07 | -3.96 |
Year over Year Growth Est. | 39.32% | 39.66% | 21.89% | 58.41% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 4 | 3 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 2 | 3 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.71 | -0.70 | -3.96 | -1.65 |
7 Days Ago | -0.71 | -0.70 | -3.96 | -1.65 |
30 Days Ago | -0.70 | -0.68 | -3.90 | -1.63 |
60 Days Ago | -0.70 | -0.68 | -3.92 | -1.64 |
90 Days Ago | -0.70 | -0.68 | -3.92 | -1.64 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.70 | -0.58 | -3.93 | -1.86 |
Zacks Consensus Estimate | -0.71 | -0.70 | -3.96 | -1.65 |
Earnings ESP | 1.41% | 17.65% | 0.83% | -12.73% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.90 | -1.76 | -1.16 | -1.17 | NA |
Estimate | -0.87 | -0.98 | -1.27 | -1.09 | NA |
Difference | -0.03 | -0.78 | 0.11 | -0.08 | -0.20 |
Surprise | -3.45% | -79.59% | 8.66% | -7.34% | -20.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more